Biotech · Private company
Aspeya, Inc.
Track this companyFree. Adds Aspeya, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- ASY202Phase 2 · MigraineClinicalTrials.gov · fetched Nov 12, 2026
- ASY202Phase 1 · Safety in Asthma PatientsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Phase 1 Study Evaluating Safety and Pharmacokinetics of ASY202 in Adults With AsthmaPHASE1 · RECRUITING · started May 26, 2026ClinicalTrials.gov NCT07665892 · fetched Nov 12, 2026
- Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult PatientsPHASE2 · RECRUITING · started May 19, 2026ClinicalTrials.gov NCT07646613 · fetched Nov 12, 2026